Vitrolife Interim Report January-June 2016: Good Growth And Broadened Product Portfolio

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

Vitrolife Sweden AB (STO:VITR)

Second quarter:

· Sales amounted to SEK 208 (184) million, corresponding to an increase of 13 percent in SEK. Net sales growth was 15 percent in local currency.